[Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
Gallego Gómez
J
J
Jiménez Cruz
J F
JF
Martínez Agulló
E
E
Mompó Sanchís
J A
JA
Llopis Mínguez
B
B
Boronat Tormo
F
F
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009530:Nicergoline / Q000627:therapeutic use*; D010643:Phenoxybenzamine / Q000627:therapeutic use; D001750:Urinary Bladder, Neurogenic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D014563:Urodynamics; D014718:Vesico-Ureteral Reflux / Q000209:etiology / Q000517:prevention & control
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D010643:Phenoxybenzamine; D009530:Nicergoline
Posibilidades terapéuticas de la nicergolina en la disfunción vesical neurógena.